Please provide your email address to receive an email when new articles are posted on . An AI-powered device to identify low left ventricular ejection fraction in patients at risk for HF gained 510(k) ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading artificial intelligence (AI)-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has included its ...
Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. About 6.2 million Americans battle ...
It still remains to be seen whether the sci-fi genre is correct and artificial intelligence will one day rise up against the human race, but in the meantime, AI just might save your life. An algorithm ...
Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, ...
Please provide your email address to receive an email when new articles are posted on . An AI model may help to detect asymptomatic heart failure using a single-lead ECG. Early diagnosis could improve ...
August 12, 2011 — Older patients are more likely than younger patients with a similar low left ventricular ejection fraction to have cognitive decline, report researchers. "Cognitive dysfunction due ...
Credit: Eko Health. The FDA clearance was based on data from a prospective clinical study of 3456 patients. The Food and Drug Administration (FDA) has cleared the Eko Low Ejection Fraction Tool (ELEFT ...
Allogeneic immunotherapy by hematopoietic stem cell transplantation (ASCT) after reduced intensity conditioning (RIC) following high-dose chemotherapy for patients with acute myeloblastic leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results